Prognostic significance of 68 Ga-FAPI PET/CT in patients with bone metastases in various cancers
View abstract on PubMed
Summary
This summary is machine-generated.Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT detects more bone metastases and higher SUVmax values than Fluorodeoxyglucose (FDG) PET/CT. Higher 68Ga-FAPI SUVmax in bone lesions predicts poorer overall survival in cancer patients.
Area Of Science
- Nuclear Medicine
- Oncology
- Radiomics
Background
- Bone metastases significantly impact cancer patient prognosis and treatment strategies.
- Accurate detection and characterization of bone lesions are crucial for staging and management.
- Comparing the efficacy of novel PET tracers like 68Ga-FAPI with established tracers like 18F-FDG in bone metastases is essential.
Purpose Of The Study
- To compare the performance of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in detecting bone metastases across various cancer types.
- To evaluate the prognostic significance of the maximum standardized uptake value (SUVmax) from 68Ga-FAPI PET/CT in bone lesions for overall survival (OS).
Main Methods
- Retrospective analysis of 75 cancer patients with bone metastases who underwent both 68Ga-FAPI PET/CT and 18F-FDG PET/CT within one week.
- Comparison of lesion detection rates and SUVmax values between the two imaging modalities.
- Statistical analysis to determine the correlation between bone lesion SUVmax and overall survival.
Main Results
- 68Ga-FAPI PET/CT detected significantly more bone lesions (median 4 vs. 2) compared to 18F-FDG PET/CT (p=0.014), particularly sclerotic lesions (p=0.001).
- Bone lesions showed higher median SUVmax values on 68Ga-FAPI PET/CT (7.8) than on 18F-FDG PET/CT (5.9).
- Higher 68Ga-FAPI SUVmax in bone lesions was significantly associated with poorer overall survival (p<0.001), whereas 18F-FDG SUVmax did not show this correlation (p=0.079).
Conclusions
- 68Ga-FAPI PET/CT offers superior detection of bone metastases and higher lesion uptake compared to 18F-FDG PET/CT in diverse cancer types.
- The SUVmax of 68Ga-FAPI bone lesions is a significant independent prognostic factor for overall survival, irrespective of cancer subtype.
- 68Ga-FAPI PET/CT holds promise for improved staging and prognostication of bone metastases in cancer patients.
Related Concept Videos
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...

